BioScrip Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
1,001.00
740.00
15,577.00
9,569.00
44,407.00
18,860
Total Accounts Receivable
187,301.00
143,210.00
97,353.00
109,086.00
85,522.00
114,864
Inventories
34,341.00
37,215.00
42,983.00
36,165.00
38,044.00
26,689
Other Current Assets
14,313.00
7,050.00
27,772.00
18,507.00
19,718.00
14,292
Total Current Assets
236,956.00
188,215.00
183,685.00
173,327.00
187,691.00
174,705
Net Property, Plant & Equipment
41,612.00
38,171.00
31,939.00
32,678.00
26,973.00
28,788
Intangible Assets
637,345.00
583,592.00
313,857.00
396,990.00
386,312.00
377,668
Other Assets
20,945.00
14,735.00
1,161.00
1,990.00
2,116.00
1,745
Total Assets
936,858.00
824,713.00
530,642.00
604,985.00
603,092.00
583,938
ST Debt & Current Portion LT Debt
60,257.00
5,395.00
24,380.00
18,521.00
1,722.00
Accounts Payable
64,342.00
90,032.00
65,077.00
64,420.00
65,963.00
Other Current Liabilities
49,707.00
66,886.00
63,307.00
47,206.00
37,445.00
Total Current Liabilities
174,306.00
162,313.00
152,764.00
130,147.00
105,130.00
Long-Term Debt
375,322.00
418,408.00
393,741.00
433,413.00
478,866.00
Deferred Taxes
15,107.00
19,058.00
236.00
2,281.00
-
Other Liabilities
17,540.00
8,129.00
1,861.00
763.00
21,769.00
Total Liabilities
582,275.00
607,908.00
548,602.00
566,604.00
605,765.00
Common Equity (Total)
354,583.00
216,805.00
80,878.00
33,621.00
84,752.00
Total Shareholders' Equity
354,583.00
216,805.00
17,960.00
38,381.00
2,673.00
Total Equity
354,583.00
216,805.00
17,960.00
38,381.00
2,673.00
Liabilities & Shareholders' Equity
936,858.00
824,713.00
530,642.00
604,985.00
603,092.00
Preferred Stock (Carrying Value)
-
-
62,918.00
72,002.00
82,079.00

About BioScrip

View Profile
Address
1600 Broadway
Denver Colorado 80202
United States
Employees -
Website http://www.bioscrip.com
Updated 07/08/2019
BioScrip, Inc. engages in the provision of home infusion and home care management solutions. It partners with physicians, hospital systems, skilled nursing facilities, healthcare payors, and pharmaceutical manufacturers to provide patients access to post-acute care services. The firm offers post-acute solutions, infusion services, and respiratory care services and home medical equipment.